AT-Patch (ATP-C130/ATP-C70) vs CVI42
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you need continuous, long-term (up to 14 days) ambulatory ECG monitoring for patients suspected of having intermittent arrhythmias or for post-treatment follow-up. Its wearable, shower-proof design and AI-powered analysis are ideal for detecting transient cardiac events in a patient's natural environment, providing comprehensive data without requiring active patient intervention beyond symptom recording.
View AT-Patch (ATP-C130/ATP-C70) →Choose CVI42 if…
Choose CVI42 if your clinical practice requires advanced, AI-enabled analysis of cardiac and vascular CT and MRI images for complex diagnostic and treatment planning purposes. This platform is best suited for cardiologists and radiologists who need detailed quantification of coronary plaque, advanced CMR automation, or comprehensive vascular analysis to enhance precision in diagnosis and surgical preparation.
View CVI42 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | CVI42 |
|---|---|---|
| Pricing | N/a | Starts at $5,000 per license. |
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch is designed for patient comfort and ease of use, being a compact, lightweight, and shower-proof wearable with a simple smartphone app for live viewing and symptom recording. CVI42, while efficient for clinicians, is a complex imaging analysis platform that likely requires specialized training for its advanced features.
Clinical Value
CVI42CVI42 offers a broader and deeper diagnostic capability for complex structural and vascular heart diseases through comprehensive AI-driven imaging analysis across multiple modalities (CT, MRI). While AT-Patch provides valuable continuous ECG data for arrhythmia detection, CVI42's detailed plaque analysis, advanced CMR automation, and vascular tools address a wider range of complex cardiac conditions.
Pricing & Value
CVI42CVI42 explicitly describes a flexible, scalable subscription model with modular licensing, offering more transparency into its pricing structure and potential for tailored value. AT-Patch's pricing is less transparent, only stating direct sales without further detail on its model.
Enterprise Readiness
CVI42CVI42, as a comprehensive imaging platform, is explicitly designed for integration into clinical workflows with DICOM connectivity to PACS and HL7 compatibility, supporting both standalone and client/server deployments. This indicates robust features for data management, integration, and scalability within a hospital imaging department. While AT-Patch's analysis software is on-premise, its distributed data collection via wearables presents different enterprise integration challenges, and its HIPAA compliance is only stated as 'likely'.
Innovation
CVI42CVI42 demonstrates more advanced AI innovation in complex cardiac imaging analysis, including novel metrics like Pericoronary Adipose Tissue (PCAT) analysis (even if research-use-only) and multi-modality capabilities such as 4D flow pre-processing. AT-Patch's innovation is strong in wearable design and long-term ECG monitoring, but CVI42 pushes the boundaries of diagnostic imaging more significantly.
Support & Docs
CVI42CVI42 offers comprehensive support resources including a customer portal, versioned documentation, archived tutorials, and workshops, backed by strong customer satisfaction testimonials. AT-Patch provides user manuals and a catalogue, but lacks the same breadth of explicit support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | CVI42 |
|---|---|---|
| Name | AT-Patch (ATP-C130/ATP-C70) | CVI42 |
| Company | ATsens Co. | CIRCLE CARDIOVASCULAR IMAGING |
| Description | FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection. | AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Cardiothoracic Surgery, Radiology |
| Key Features | Up to 14 days of continuous ECG monitoring (ATP-C130), High-performance sensor chip for accurate ECG signal acquisition, Short-length electrode to minimize motion artifact noise, Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), No charging or electrode replacement required during monitoring, Compact and lightweight (13g) for patient comfort, AT-Note smartphone app for live ECG viewing and symptom recording, AT-Report software with AI/machine learning algorithms for ECG analysis | AI-automated coronary lumen and wall segmentation, Comprehensive coronary plaque analysis (calcified, non-calcified, low-attenuation), Advanced CMR automation (T1 mapping, 4D flow pre-processing), Vascular CT analysis and planning tools, Automated detection of suspected coronary lesions, Pericoronary Adipose Tissue (PCAT) analysis (research use only), 3D visualization and image fusion, Automated contouring of regions of interest |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and CVI42.